Kurzporträt
Mitarbeiterzahl: 130
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Ronald Cooper
CEO | Chief Executive Officer | 61 | 01.06.15 |
Founder | 60 | 08.12.03 | |
President | 57 | 02.03.23 | |
Joan Connolly
CTO | Chief Tech/Sci/R&D Officer | - | 13.04.21 |
Paul Streck
CTO | Chief Tech/Sci/R&D Officer | 60 | 19.12.22 |
Heather White
CTO | Chief Tech/Sci/R&D Officer | - | 02.03.23 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Corporate Secretary | - | 02.03.23 | |
Michelle Graham
HRO | Human Resources Officer | 57 | 04.11.19 |
Muffy Carter
LAW | General Counsel | 71 | 29.11.16 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Director/Board Member | 54 | 02.03.23 | |
Director/Board Member | 61 | 02.03.23 | |
Ronald Cooper
CEO | Chief Executive Officer | 61 | 01.06.15 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 20 709 043 | 18 650 831 ( 90,06 %) | 7 760 ( 0,0375 %) | 90,06 % |
Unternehmenskontakt
Albireo Pharma, Inc.
53 State Street 19th Floor
02109, Boston
+857 254 5555
Sektor
% 1. Jan. | Kap. | |
---|---|---|
-1.51% | 104 Mrd. | |
+3.22% | 97.42 Mrd. | |
+1.05% | 22.2 Mrd. | |
-16.53% | 21.23 Mrd. | |
-8.72% | 18.33 Mrd. | |
-42.33% | 16.35 Mrd. | |
-20.09% | 15.06 Mrd. | |
+5.47% | 13.98 Mrd. | |
+28.85% | 11.66 Mrd. |